The nephrotoxin ochratoxin A induces key parameters of chronic interstitial nephropathy in renal proximal tubular cells

Cellular Physiology and Biochemistry

Volumn 15, Issue 1-4, 2005, Pages 125-134

  Sauvant, Christoph ^a   Holzinger, Hildegard ^a   Gekle, Michael ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Apoptosis; Epithelial tightness; Epithelial to mesenchymal transition; ERK1 2; Fibrosis; Inflammation; Interstitial nephropathy; Necrosis; Ochratoxin A; Renal disease

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CASPASE 3; CELL PROTEIN; DNA; FLUORESCEIN ISOTHIOCYANATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INULIN; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OCHRATOXIN; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL COUNT; CONTROLLED STUDY; DIFFUSION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM; FIBROSIS; INCUBATION TIME; INFLAMMATION; INTERSTITIAL NEPHRITIS; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; MESENCHYME; NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT;

EID: 12444345857     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083660     Document Type: Article

References (42)

1. Walker R: Risk assessment of ochratoxin: current views of the European Scientific Committee on Food, the JECFA and the Codex Committee on Food Additives and Contaminants. Adv Exp Med Biol 2002;504:249-255.
2. Wolf G, Ochratoxin A: Contamination of Foods and Consumer Exposures. Arch. Lebensmittelhygiene 2000;51:81-128.
3. Gekle M, Sauvant C, Schwerdt G, Silbernagl S: Tubulotoxic mechanisms of Ochratoxin A. Kidney Blood Press Res 1998;21:277-279.
4. Krogh P, Axelsen NH, Elling F, Gyrd-Hansen N, Hald B, Hyldgaard-Jensen J, Larsen AE, Madsen A, Mortensen HP, Moller T, Petersen OK, Ravnskov U, Rostgaard M, Aalund O: Experimental porcine nephropathy. Changes of renal function and structure induced by ochratoxin A- contaminated feed. Acta PatholMicrobiol Scand [A]. 1974;1-21.
5. Schlatter C, Studer-Rohr J, Rasonyi T: Carcinogenicity and kinetic aspects of ochratoxin A. Food Addit Contam 1996;13:43-44.
6. Petzinger E, Ziegler K: Ochratoxin A from a toxicological perspective. J Vet Pharmacol Ther 2000;23:91-98.
7. Vrabcheva T, Petkova-Bocharova T, Grosso F, Nikolov I, Chernozemsky IN, Castegnaro M, Dragacci S: Analysis of ochratoxin A in foods consumed by inhabitants from an area with balkan endemic nephropathy: a 1 month follow-up study. J Agric Food Chem 2004;52:2404-2410.
8. Abouzied MM, Horvath AD, Podlesny PM, Regina NP, Metodiev VD, Kamenova-Tozeva RM, Niagolova ND, Stein AD, Petropoulos EA, Ganev VS: Ochratoxin A concentrations in food and feed from a region with Balkan Endemic Nephropathy. Food Addit Contam 2002;19:755-764.
9. Rodriguez-Barbero A: NTP Technical report on the toxicology and carcinogenesis studies on ochratoxin A (CAS NO. 303-47-8) in F334/N rats (Gavage studies). 1989.
10. Ochratoxin A: IARC Monogr Eval Carcinog Risks Hum 1993;56:489-521.
11. Klahr S, Morrissey J: Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 2002;283:F861-F875.
12. Eddy AA, Giachelli CM: Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int 1995;47:1546-1557.
13. Klahr S, Morrissey J: Progression of chronic renal disease. Am J Kidney Dis 2003;41:S3.-7.
14. Liu Y: Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 2004;15:1-12.
15. Krogh P: Role of ochratoxin in disease causation. Food Chem Toxicol 1992;30:213-224.
16. Aukema HM, House JD, Bankovic-Calic N, Ogborn MR: Increased renal fibrosis and expression of renal phosphatidylinositol 4-kinase-beta and phospholipase C(gamma1) proteins in piglets exposed to ochratoxin-A. Nephron Physiol 2004;96:P19-25.
17. Remuzzi G, Bertani T: Pathophysiology of progressive nephropathies. N Engl J Med 1998;339:1448-1456.
18. Horvath A, Upham BL, Ganev V, Trosko JE: Determination of the epigenetic effects of ochratoxin in a human kidney and a rat liver epithelial cell line. Toxicon 2002;40:273-282.
19. Schramek H, Wilflingseder D, Pollack V, Freudinger R, Mildenberger S, Gekle M: Ochratoxin A-induced stimulation of extracellular signal- regulated kinases 1/2 is associated with madin-darby canine kidney-C7 cell dedifferentiation. J Pharmacol Exp Ther 1997;283:1460-1468.
20. Gekle M, Schwerdt G, Freudinger R, Mildenberger S, Wilflingseder D, Pollack V, Dander M, Schramek H: Ochratoxin A induces JNK activation and apoptosis in MDCK-C7 cells at nanomolar concentrations. J Pharmacol Exp Ther 2000;293:837-844.
21. Versteeg HH, Nijhuis E, van den Brink GR, Evertzen M, Pynaert GN, van Deventer SJ, Coffer PJ, Peppelenbosch MP: A new phosphospecific cell-based ELISA for p42/p44 mitogen-activated protein kinase (MAPK), p38 MAPK, protein kinase B and cAMP-response-element-binding protein. Biochem J 2000;350:717-722.
22. Krug AW, Schuster C, Gassner B, Freudinger R, Mildenberger S, Troppmair J, Gekle M: Human epidermal growth factor receptor-1 expression renders Chinese hamster ovary cells sensitive to alternative aldosterone signaling. J Biol Chem 2002;277:45892-45897.
23. Schwerdt G, Freudinger R, Mildenberger S, Silbernagl S, Gekle M; The nephrotoxin ochratoxin A induces apoptosis in cultured human proximal tubule cells. Cell Biol Toxicol 1999;15:405-415.
24. Gekle M, Knaus P, Nielsen R, Mildenberger S, Freudinger R, Wohlfarth V, Sauvant C, Christensen EI: TGFβ1 reduces megalin/cubilin-mediated endocytosis of albumin in proximal tubule-derived OK-cells. Nephrol Dial Transplant 2003;18:561-561.
25. Li JH, Zhu HJ, Huang XR, Lai KN, Johnson RJ, Lan HY: Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation. J Am Soc Nephrol 2002;13:1464-1472.
26. Sauvant C, Silbernagl S, Gekle M: Exposure to ochratoxin A impairs organic anion transport in proximal- tubule-derived opossum kidney cells. J Pharmacol Exp Ther 1998;287:13-20.
27. Pfohl-Leszkowicz A, Petkova-Bocharova T, Chernozemsky IN, Castegnaro M: Balkan endemic nephropathy and associated urinary tract tumours: a review on aetiological causes and the potential role of mycotoxins. Food Addit Contam 2002;19:282-302.
28. Lentsch AB, Ward PA: The NFkappaBb/IkappaB system in acute inflammation. Arch Immunol Ther Exp (Warsz) 2000;48:59-63.
29. Yang J, Liu Y: Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 2001;159:1465-1475.
30. Masszi A, Di Ciano C, Sirokmany G, Arthur WT, Rotstein OD, Wang J, McCulloch CA, Rosivall L, Mucsi I, Kapus A: Central role for Rho in TGF-beta1-induced alpha-smooth muscle actin expression during epithelial-mesenchymal transition. Am J Physiol Renal Physiol 2003;284:F911-F924.
31. Kiely B, Feldman G, Ryan MP: Modulation of renal epithelial barrier function by mitogen-activated protein kinases (MAPKs): mechanism of cyclosporine A-induced increase in transepithelial resistance. Kidney Int 2003;63:908-916.
32. Baudrimont I, Betbeder AM, Creppy EE: Reduction of the ochratoxin A-induced cytotoxicity in Vero cells by aspartame. Arch Toxicol 1997;71:290-298.
33. Scibelli A, Tafuri S, Ferrante MC, Alimenti E, Naso B, Lucisano A, Staiano N, Della MR: Ochratoxin A affects COS cell adhesion and signaling. Toxicol Appl Pharmacol 2003;192:222-230.
34. Mezzano SA, Barria M, Droguett MA, Burgos ME, Ardiles LG, Flores C, Egido J: Tubular NF-kappaB and AP-1 activation in human proteinuric renal disease. Kidney Int 2002;60:1366-1377.
35. Parenti A, Cui XL, Hopfer U, Ziche M, Douglas JG: Activation of MAPKs in proximal tubule cells from spontaneously hypertensive and control Wistar-Kyoto rats Hypertension 2000;35:1160-1166.
36. Takaya K, Koya D, Isono M, Sugimoto T, Sugaya T, Kashiwagi A, Haneda M: Involvement of ERK pathway in albumin-induced MCP-1 expression in mouse proximal tubular cells. Am J Physiol Renal Physiol. 2003;284:F1037-1045.
37. Pearson G, Robinson F, Beers GT, Xu BE, Karandikar M, Berman K, Cobb MH: Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 2001;22:153-183.
38. Tian W, Zhang Z, Cohen DM: MAPK signaling and the kidney. Am J Physiol Renal Physiol 2001;279:F593-604.
39. Arany I, Megyesi JK, Kaneto H, Tanaka S, Safirstein RL: Activation of ERK or inhibition of JNK ameliorates H(2)O(2) cytotoxicity in mouse renal proximal tubule cells. Kidney Int 2004;65:1231-1239.
40. Li JH, Wang W, Huang XR, Oldfield M, Schmidt AM, Cooper ME, Lan HY: Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway. Am J Pathol 2004;164:1389-1397.
41. Oka H, Chatani Y, Hoshino R, Ogawa O, Kakehi Y, Terachi T, Okada Y, Kawaichi M, Kohno M, Yoshida O: Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. Cancer Res 1995;55:4182-4187.
42. Cuadrado A, Garcia-Fernandez LF, Gonzalez L, Suarez Y, Losada A, Alcaide V, Martinez T, Fernandez-Sousa JM, Sanchez-Puelles JM, Munoz A: Aplidin induces apoptosis in human cancer cells via glutathione depletion and sustained activation of the epidermal growth factor receptor, Src, JNK, and p38 MAPK. J Biol Chem 2003;278:241-250.